Abstract | BACKGROUND: Human herpesvirus 6 (HHV-6) is an important cause of fulminant or acute viral myocarditis. However, insufficiency of standard antiviral treatment against HHV-6 is an emerging problem. OBJECTIVES: STUDY DESIGN: Case report supported by histological and viral diagnoses via a combination of histology/immunohistochemistry and polymerase chain reaction techniques performed on cardiac tissues before and after treatment. RESULTS: Following therapeutic intervention, the clinical status and heart function improved. Endomyocardial biopsies revealed decreased levels of HHV-6B DNA in the myocardium and the disappearance of histological findings in support of lymphocytic myocarditis. Left ventricular assist device could be explanted. No adverse effects of Artesunate were noted. CONCLUSIONS:
|
Authors | Nina Hakacova, Karin Klingel, Reinhard Kandolf, Elin Engdahl, Anna Fogdell-Hahn, Thomas Higgins |
Journal | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
(J Clin Virol)
Vol. 57
Issue 2
Pg. 157-60
(Jun 2013)
ISSN: 1873-5967 [Electronic] Netherlands |
PMID | 23473961
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Antiviral Agents
- Artemisinins
- Artesunate
|
Topics |
- Antiviral Agents
(pharmacology, therapeutic use)
- Artemisinins
(pharmacology, therapeutic use)
- Artesunate
- Heart-Assist Devices
- Herpesvirus 6, Human
(drug effects, genetics)
- Humans
- Infant
- Myocarditis
(drug therapy, virology)
- Polymerase Chain Reaction
- Roseolovirus Infections
(drug therapy, virology)
- Treatment Outcome
- Ventricular Dysfunction, Left
(pathology, therapy)
|